These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36064229)

  • 1. Interference of immunogenic chemotherapy by artificially controlled calreticulin secretion from tumor cells.
    Zhao L; Zhang S; Chen H; Kroemer G; Kepp O; Liu P
    Methods Cell Biol; 2022; 172():99-114. PubMed ID: 36064229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis.
    Kepp O; Liu P; Zhao L; Plo I; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1792037. PubMed ID: 32923154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
    Liu P; Zhao L; Loos F; Marty C; Xie W; Martins I; Lachkar S; Qu B; Waeckel-Énée E; Plo I; Vainchenker W; Perez F; Rodriguez D; López-Otin C; van Endert P; Zitvogel L; Kepp O; Kroemer G
    Mol Cell; 2020 Feb; 77(4):748-760.e9. PubMed ID: 31785928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells.
    Liu X; Sun N; Dong Y; Li J; Liu Y; Ren Y; Yang C; Zhang L; Zhou Y; Tong Z; Ding J; Zhao X; Liu Y; He R; Xu K; Wu Y; Huang Y; Wang H; Tao X; Liu Y
    Int Immunopharmacol; 2015 Apr; 25(2):416-24. PubMed ID: 25704851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of calreticulin exposure associated with immunogenic cell death.
    Liu P; Zhao L; Kepp O; Kroemer G
    Methods Enzymol; 2020; 632():1-13. PubMed ID: 32000891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin and cancer.
    Fucikova J; Spisek R; Kroemer G; Galluzzi L
    Cell Res; 2021 Jan; 31(1):5-16. PubMed ID: 32733014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
    Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
    Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
    Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
    Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted calreticulin mutants subvert anticancer immunosurveillance.
    Liu P; Zhao L; Kroemer G; Kepp O
    Oncoimmunology; 2020; 9(1):1708126. PubMed ID: 32002304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
    Kielbik M; Szulc-Kielbik I; Klink M
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF2α phosphorylation is pathognomonic for immunogenic cell death.
    Bezu L; Sauvat A; Humeau J; Gomes-da-Silva LC; Iribarren K; Forveille S; Garcia P; Zhao L; Liu P; Zitvogel L; Senovilla L; Kepp O; Kroemer G
    Cell Death Differ; 2018 Aug; 25(8):1375-1393. PubMed ID: 29358668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients.
    Kasikova L; Hensler M; Truxova I; Skapa P; Laco J; Belicova L; Praznovec I; Vosahlikova S; Halaska MJ; Brtnicky T; Rob L; Presl J; Kostun J; Cremer I; Ryska A; Kroemer G; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2019 Nov; 7(1):312. PubMed ID: 31747968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
    Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
    Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
    Kofla G; Radecke C; Frentsch M; Walther W; Stintzing S; Riess H; Bullinger L; Na IK
    Oncoimmunology; 2022; 11(1):2068109. PubMed ID: 35496500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytofluorometric assessment of calreticulin exposure on CD38
    Beltrán-Visiedo M; Serrano-Del Valle A; Jiménez-Aldúan N; Soler-Agesta R; Naval J; Galluzzi L; Marzo I
    Methods Cell Biol; 2024; 189():189-206. PubMed ID: 39393883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming tumor microenvironment with precise photothermal therapy by calreticulin nanobody-engineered probiotics.
    Zheng L; Wang H; Zhong X; Jia L; Shi G; Bai C; Yang R; Huang Z; Jiang Y; Wei J; Dong Z; Li J; Long Y; Dai L; Li Z; Chen C; Wang J
    Biomaterials; 2024 Sep; 314():122809. PubMed ID: 39303415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.